EXPANDED TABLE OF CONTENTS
VOLUME 11, NUMBER 5 MAY 2008
|
| TREATMENT HIGHLIGHTS |
| CHRONICITY OF DEPRESSION |
| In approximately half of all cases of major depression, the course of the disorder is found to be chronic, either in the form of recurring depressive episodes or as unremitting depression. |
| DEPRESSION AND SELF-CARE IN DIABETES |
| Depressive symptoms, even at levels too low to warrant a diagnosis of major depression, are found to be associated with poorer diabetes self-care. |
| SELF-HARM IN FIRST-EPISODE PSYCHOSIS |
| Among individuals with first-time psychosis, self-harm is found to be common prior to receiving treatment. |
| QUICKSTATS |
| 2008 "Sleep in America" Poll |
| PSYCHOTROPIC DRUG COMPARISON STUDY |
| TREATMENT STRATEGIES FOR SSRI-RESISTANT DEPRESSION IN ADOLESCENTS |
| In the treatment of SSRI-resistant depression in adolescents, switching to another SSRI is found to have advantages over switching to venlafaxine. Also, when switching medications, adding cognitive-behavioral therapy (CBT) is found to improve outcome. |
| FDA NEWS AND REVIEW |
| Approval (new indications): Several indications for the use of Abilify (aripiprazole) have been expanded pertaining to age of patient, and/or maintenance therapy, and/or adjunctive use. |
| Approval (new indication): Vyvanse (lisdexamfetamine dimesylate) is now approved for use in adults for the treatment of attention-deficit/hyperactivity disorder (ADHD). (It previously was indicated for use only in children.) |
| ASSESSMENT |
| Multidimensional Students’ Life Satisfaction Scale (MSLSS) |
| RESOURCES |
| Each issue presents descriptions of clinical resources (eg, professional materials, patient handouts) and information on how to receive those materials. |
